Literature DB >> 7753563

Resting B-cells, EBV-infected B-blasts and established lymphoblastoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns.

L Szekely1, K Pokrovskaja, W Q Jiang, G Selivanova, M Löwbeer, N Ringertz, K G Wiman, G Klein.   

Abstract

Using immunofluorescence technique we have analysed the Rb, p53, EBNA-2 and EBNA-5 expression pattern in EBV infected human B-cells and established lymphoblastoid cell lines (LCL-s). Resting B-cells showed only a faint Rb and no p53 immunostaining. The expression of both Rb and p53 increased after EBV infection. The change was first detectable 6 h after infection. The frequency of brilliantly Rb positive cells increased more rapidly than p53 positives. EBNA-2 and EBNA-5 became first detectable 12 h after infection. The frequency of EBNA positive cells in the freshly infected cultures was concordant with the proportion of CD23 and PCNA positives, but remained consistently below the frequency of Rb and p53 positive cells. Double immunofluorescence staining showed that all EBNA-5 positive cells were strongly Rb and p53 positive. LCL-s did not stain for p53, whereas the Rb staining was maintained at a high level. The EBNA-5 staining pattern changed from brilliant almost homogeneous nuclear staining in the freshly infected B-cells, to a nonhomogeneous pattern with a small number of strongly fluorescent nuclear bodies in established LCL-s. There was no change in the EBNA-2 staining pattern. Our findings indicate that the immortalization of B-cells by EBV may initially involve a high expression of EBNA-5, p53 and Rb, but only cells with low p53 and focal expression of EBNA-5 in nuclear bodies have the selective advantage required to grow into immortalized lines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753563

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation.

Authors:  Martin Dufva; Josefine Flodin; Annika Nerstedt; Ulla Rüetschi; Lars Rymo
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

2.  Multiple functions within the Epstein-Barr virus EBNA-3A protein.

Authors:  I Cludts; P J Farrell
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

3.  Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappaB activity.

Authors:  W Chen; N R Cooper
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  Detection of p53 in inflammatory tissue and lymphocytes using immunohistology and flow cytometry: a critical comment.

Authors:  A Nickels; H Selter; M Pfreundschuh; M Montenarh; B Koch
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

5.  Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100.

Authors:  Paul D Ling; Rong Sheng Peng; Ayako Nakajima; Jiang H Yu; Jie Tan; Stephanie M Moses; Wei-Hong Yang; Bo Zhao; Elliott Kieff; Kenneth D Bloch; Donald B Bloch
Journal:  EMBO J       Date:  2005-09-22       Impact factor: 11.598

6.  The Epstein-Barr virus immediate-early gene product, BRLF1, interacts with the retinoblastoma protein during the viral lytic cycle.

Authors:  V L Zacny; J Wilson; J S Pagano
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis.

Authors:  D Islam; B Veress; P K Bardhan; A A Lindberg; B Christensson
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

8.  The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies.

Authors:  L Szekely; K Pokrovskaja; W Q Jiang; H de The; N Ringertz; G Klein
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Truncated form of the Epstein-Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A.

Authors:  Julie Garibal; Emilie Hollville; Andrew I Bell; Gemma L Kelly; Benjamin Renouf; Yasushi Kawaguchi; Alan B Rickinson; Joëlle Wiels
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

10.  A novel antibody discovery platform identifies anti-influenza A broadly neutralizing antibodies from human memory B cells.

Authors:  Xiaodong Xiao; Yan Chen; Reena Varkey; Nicole Kallewaard; Adem C Koksal; Qing Zhu; Herren Wu; Partha S Chowdhury; William F Dall'Acqua
Journal:  MAbs       Date:  2016-04-06       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.